Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Scarring: early-phase trial registry

5 of 9 indexed Scarring trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Scarring: 9 US clinical trials tracked, 5 recruiting.

Scarring is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 4 of these trials.

Enrollment posture brief

Registry condition scarring

OPEN 5 | RECR 56% | LATE 0 | EARLY 3 | RANK #1916 | SPON 4

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Scarring (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Scarring

Scarring lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Scarring on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Scarring is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Scarring research.

    University of California, Davis accounts for 4 of 9 trials (44.4%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Scarring trials plan to enrol fewer than 100 people.

    Median target enrolment is 52 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.

  4. Scarring research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2

Named interventions

Most-linked intervention names on Scarring records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Dehydrated Human Amnion/Chorion Membrane (dHACM) Other
1 trials
Microdiscectomy Surgery Procedure
1 trials
Lumbar Decompression Surgery Procedure
1 trials
Normal Saline Injection Drug
1 trials
Application of dHACM Other
1 trials
Botulinum Toxin Type A Drug
1 trials
Granexin® gel 200 μM Drug
1 trials
Granexin® gel 100 μM Drug
1 trials

US sites by state

Facility locations filed on Scarring trials. A trial with sites in several states counts in each.

California 5 trials
Texas 2 trials
New York 2 trials
Utah 1 trials
North Carolina 1 trials
Illinois 1 trials
Iowa 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Scarring page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Scarring condition card totals 9 registered trials; most-linked intervention Dehydrated Human Amnion/Chorion Membrane (dHACM); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.